International Hepato-Pancreato-Biliary Association
IHPBA News
-
Treatment Results of SIR-Spheres® Y-90 Resin Microspheres are Similar Regardless of Patient Age, New Publication Shows
Treatment Results of SIR-Spheres® Y-90 Resin Microspheres are Similar Regardless of Patient Age, New Publication Shows 606-patient MORE Study Sub-Group Analysis Examined Outcomes for Elderly (?70...
Published
Read more -
Netherlands Healthcare Institute Approves Reimbursement of Selective Internal Radiation Therapy (SIRT) for Patients with Colorectal Liver Metastases Who Have Failed Prior Treatment
Netherlands Healthcare Institute Approves Reimbursement of Selective Internal Radiation Therapy (SIRT) for Patients with Colorectal Liver Metastases Who Have Failed Prior Treatment Bonn, Germany...
Published
Read more -
Leading South African Health Insurer Approves Reimbursement of SIR-Spheres® Y-90 resin microspheres for Patients with Liver Tumours
Leading South African Health Insurer Approves Reimbursement of SIR-Spheres® Y-90 resin microspheres for Patients with Liver Tumours Bonn, Germany (12 May 2016) – Sirtex (ASX:SRX) announced that...
Published
Read more -
SIRFLOX Study Published in Journal of Clinical Oncology
SIRFLOX Study Published in Journal of Clinical Oncology Prestigious ASCO Journal Publishes 530-patient SIRFLOX Study on SIR-Spheres® Y-90 resin microspheres in the Management of Metastatic...
Published
Read more -
SIR-Spheres® Y-90 resin microspheres Are a Well-Tolerated Alternative to Standard Therapies for Inoperable Primary Liver Cancer, New UK NICE Medtech Innovation Briefing Says
SIR-Spheres® Y-90 resin microspheres Are a Well-Tolerated Alternative to Standard Therapies for Inoperable Primary Liver Cancer, New UK NICE Medtech Innovation Briefing Says London, 31st of March...
Published
Read more
Corporate Partners
If you are interested in becoming a Corporate Partner of the IHBPA please contact industry@ihpba.org
Find out more